Our Pipeline
Together with Danish partner Ranger Biotechnologies A/S, we are focus on developing new medicines for diseases of the liver, the CNS and the eye. There are some current R&D projects and progress, please check the below information:
Retinal Scarring
Preclinical stage
Fibrosis in heart muscle
Preclinical stage
NASH
Discovery stage
Neurodegenerative/neurovascular disease
Discovery stage